Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

180
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
180
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

244
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
244
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

143
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
143
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.9K
Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

1.9K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.9K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

334
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
334

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diverse Presentations of Mycobacterial Disease: a Case Series of Disseminated BCGosis in an Infant and Cutaneous Mycobacterium abscessus Infection in an Adolescent in Central India with Scoping Review of the Literature.

Maedica·2026
Same author

Chronic Suppurative Lung Disease in Children: A Case Based Approach.

Indian journal of pediatrics·2023
Same author

Protein estimation in whole lung lavage fluid in hereditary pulmonary alveolar proteinosis due to a novel GM-CSF receptor mutation.

Pediatric pulmonology·2022
Same author

Active toxoplasmosis presenting with polymyositis and pleural effusion in a child.

Journal of paediatrics and child health·2021
Same author

Flexible through rigid bronchoscopy for airway foreign body: A good marriage of convenience!

Pediatric pulmonology·2020

Related Experiment Video

Updated: Jul 8, 2025

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

7.9K

Shortened Treatment Regimens for Drug Sensitive TB.

Kamal Kumar Singhal1, Milind Shinde2

  • 1Department of Pediatrics, Lady Hardinge Medical College and Kalawati Saran Children's Hospital, New Delhi, 110001, India. drkksinghal@gmail.com.

Indian Journal of Pediatrics
|December 15, 2023
PubMed
Summary

Shorter tuberculosis treatment regimens offer a promising solution to improve patient compliance and reduce drug toxicity. Recent guidelines endorse a 4-month regimen for certain cases, aiming for better outcomes.

Keywords:
Pediatric tuberculosisPulmonary tuberculosisShortened ATTTuberculous meningitis

More Related Videos

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

8.7K
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

1.8K

Related Experiment Videos

Last Updated: Jul 8, 2025

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

7.9K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

8.7K
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

1.8K

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Pharmacology

Background:

  • Tuberculosis (TB) remains a significant global health issue, complicated by treatment side effects and long regimen durations.
  • Antitubercular therapy (ATT) challenges include patient adherence and drug-related morbidity, necessitating improved treatment strategies.

Purpose of the Study:

  • To review current evidence and guidelines for shortened, intensive treatment regimens for drug-sensitive tuberculosis.
  • To highlight the benefits of shorter TB treatment durations, including improved compliance and reduced adverse effects.

Main Methods:

  • Review of recent clinical trials and World Health Organization (WHO) guidelines on shortened TB treatment.
  • Analysis of the role of specific drugs like fluoroquinolones and rifapentine in regimen shortening.
  • Examination of safety monitoring and clinical response assessment for shorter regimens.

Main Results:

  • The WHO now recommends a 4-month ATT regimen for non-severe, drug-sensitive TB cases.
  • Ongoing trials are evaluating shorter regimens for severe forms like tubercular meningitis (TBM).
  • Shortened regimens may require closer monitoring for adverse effects and potential conversion to longer courses.

Conclusions:

  • Shorter TB treatment regimens can decrease patient and healthcare burdens, improve compliance, and lower drug-related side effects.
  • The adoption of shorter, intensive regimens represents a significant advancement in managing drug-sensitive tuberculosis.
  • Further research and close monitoring are essential for optimizing the use of shortened TB treatment protocols.